Lowering the TG/HDL-C ratio can prevent type 2 diabetes and type 2 diabetes.

Published Date: 17 Mar 2023

Iran: According to a study published in Diabetology and Metabolic Syndrome, triglycerides are elevated in normoglycemic patients.

Read Full News

Latest News

Continuous Glucose Monitoring Expands in Type 2 Diabetes

Continuous glucose monitoring is expanding beyond type 1 diabetes, offering detailed glycemic insights that may support earlier intervention in patients with type 2 diabetes.

Can Oestrogen Patches Replace LHRH Agonists for Prostate Tx?

Transdermal oestradiol patches are non-inferior to luteinising hormone-releasing hormone agonists for metastasis free survival in locally advanced prostate cancer, a study shows.

Prior Bariatric Surgery Lowers Postop Risk Over GLP-1s

Another Pregnancy Can Worsen Insulin Sensitivity Over Time

In parous women, an additional pregnancy is linked to a selective decline in whole-body insulin sensitivity over 10 years, with no clear changes in beta-cell function or blood glucose levels.

US FDA Clarifies Policies on Compounding Of GLP-1 Medicines

The U.S. Food and Drug Administration on Wednesday clarified its policies on compounded versions of ⁠popular GLP-1 drugs, signaling tighter limits on their production as...

Tirzepatide Effective Despite Weight-Inducing Meds

Tirzepatide is linked to significant weight loss in adults with overweight or obesity who are taking weight-inducing medications, suggesting benefits even when these therapies are continued.

Todays Updates

Why Encouragement May Not Improve Motivation in Depression

A meta-analysis identifies impaired effort-based decision making across psychiatric disorders, pointing to actionable targets for improving motivation and functional outcomes.

Assisted Dying Under Scrutiny From Medscape's Readers

Comments on a Medscape feature push past ideology to ask what evidence, oversight, and safeguards should be available for patients who choose assisted death.

Chemotherapy Boosts Survival for Older Patients With TNBC

Patients aged 70 years or older stand to benefit from adjuvant chemotherapy for triple-negative breast cancer, but the majority do not receive it.

Venetoclax Combo Shows Promise in Younger Patients With AML

Researchers conducted a systematic review and meta-analysis for studies of acute myeloid leukemia patients with a median age less than 70 treated with HMA plus venetoclax.

Radioligand Therapy Set to Transform Oncology Care

Nearly 400 trials and Belgium’s isotope hub signal rapid clinical diversification for radioligand therapy — but policy, funding, and system readiness must follow.

Todays Updates

Why Encouragement May Not Improve Motivation in Depression

A meta-analysis identifies impaired effort-based decision making across psychiatric disorders, pointing to actionable targets for improving motivation and functional outcomes.

Assisted Dying Under Scrutiny From Medscape's Readers

Comments on a Medscape feature push past ideology to ask what evidence, oversight, and safeguards should be available for patients who choose assisted death.

Chemotherapy Boosts Survival for Older Patients With TNBC

Patients aged 70 years or older stand to benefit from adjuvant chemotherapy for triple-negative breast cancer, but the majority do not receive it.

Venetoclax Combo Shows Promise in Younger Patients With AML

Researchers conducted a systematic review and meta-analysis for studies of acute myeloid leukemia patients with a median age less than 70 treated with HMA plus venetoclax.

Radioligand Therapy Set to Transform Oncology Care

Nearly 400 trials and Belgium’s isotope hub signal rapid clinical diversification for radioligand therapy — but policy, funding, and system readiness must follow.

Latest News

Continuous glucose monitoring is expanding beyond type 1 diabetes, offering detailed glycemic insights that may support earlier intervention in patients with type 2 diabetes.

Transdermal oestradiol patches are non-inferior to luteinising hormone-releasing hormone agonists for metastasis free survival in locally advanced prostate cancer, a study shows.

In parous women, an additional pregnancy is linked to a selective decline in whole-body insulin sensitivity over 10 years, with no clear changes in beta-cell function or blood glucose levels.

The U.S. Food and Drug Administration on Wednesday clarified its policies on compounded versions of ⁠popular GLP-1 drugs, signaling tighter limits on their production as...

Tirzepatide is linked to significant weight loss in adults with overweight or obesity who are taking weight-inducing medications, suggesting benefits even when these therapies are continued.

News All Time

Novo Nordisk Cuts Ozempic, Wegovy Prices in India Again to Fight Cheaper Generics

Novo Nordisk has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and ⁠48% in India, to fend off competition from...

Tirzepatide Boosts Metabolic Health in Partial Lipodystrophy

Tirzepatide significantly improves metabolic health and reduces insulin dependence in patients with partial lipodystrophy.

EMA Clears New First-Line Options for Advanced Cancers

European regulators have backed RET inhibitor and PD-1 regimens, expanding first line options in advanced lung, thyroid, and esophageal cancers.

NICE Introduces Endometriosis Fertility Pathway

An updated NICE guideline sets out a dedicated pathway for endometriosis within wider fertility guidance.

Weight Loss May Cut Cancer Risk in Adults With Obesity

Nonsurgical weight loss is associated with reduced incident risks for both obesity-related and other cancers in adults with obesity.

Medtronic Gets US FDA Nod to Use Surgical System in Cranial, ENT Surgeries

Medtronic said on Friday the U.S. Food and Drug Administration has cleared its surgical system ⁠for cranial and ear, nose and throat procedures, expanding the platform...

EU Reaffirms Rejection of Rare Sleep Disorder Drug

The sleep drug failed to gain approval for nighttime disruptions in children with a rare genetic disorder affecting circadian rhythm patterns.

Experts Question Evidence for New Testosterone Advice

New federal dietary guidance includes advice on boosting testosterone levels, which clinicians say is only partially rooted in evidence.

Once- or Twice-Yearly Injection for Weight Loss?

Phase 1 data suggest that WVE-007, an investigational siRNA drug given by injection, leads to reductions in visceral fat, waist circumference, and body weight.

Do ESAs for Anemia Raise Cancer Risk in Dialysis Patients?

High doses of erythropoiesis-stimulating agents were associated with an increased risk for cancer in patients on dialysis, but the real risk attributed to these medications remains unclear.

Ontario Government Proposes New Integrated EMR System

As Ontario proposes a new connected primary care medical record system, healthcare advocates are hoping to avoid the perils of previous attempts.

FDA Approves First Once-Weekly Insulin for Type 2 Diabetes

Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.

US FDA Approves Novo's Insulin Injection for Type 2 Diabetes

The U.S. Food and Drug ⁠Administration has approved Novo Nordisk's insulin injection, ⁠Awiqli, to control blood sugar levels ⁠in adults ‌living with type 2 diabetes, the...

Dad’s Nicotine Use May Shape Kids’ Metabolic Health

Paternal nicotine use alters metabolism in offspring, and those changes are sex-specific, a study in mice shows.

Dementia Risk May Triple With Type 1 Diabetes

The risk for dementia is significantly higher in people with diabetes, with the greatest risk among those with type 1 disease, new research shows.

Elinzanetant Reduces Vasomotor Symptoms in Breast Cancer

Elinzanetant reduces the severity and frequency of hot flushes and night sweats among women with breast cancer regardless of type of endocrine treatment used.

Recommended News For You

Study shows virtual reality headsets may help ease cancer pain

De-Intensified Therapy Misses Mark in HPV-Positive Oropharyngeal Cancer

Cancer Diagnoses Slow to Recover From Effects of COVID Pandemic

Hemihedral resection not necessary for neuroendocrine surgery after appendicitis

Could AI plus lasers help catch very early breast cancers?

'Dawson's Creek' Star Has Cancer; Radiotherapy Tattoos; Case of 'Petticoat' Cancer

Second opinions don't significantly delay breast cancer treatment

Recommended Articles For You

What is Mullerian and How Does it Affect Your Health 

How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care? 

The benefits of using magnesium sulfate during pregnancy  

Understanding Carcinoid Tumors: Diagnosis, Symptoms, and Treatment Options  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Treating advanced prostate cancer

2.

For treatment, the majority of cancer patients choose complementary therapies.

3.

Study opens up possibility of bespoke prostate cancer treatment

4.

In cases of metastatic or recurrent head and neck cancer, gene-guided immunotherapy falls short.

5.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

1.

CAR T-Cell Therapy: Revolutionizing Hematologic Malignancies

2.

Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion

3.

Understanding Sideroblastic Anemia and its Symptoms 

4.

A New Hope: How Procarbazine is Revolutionizing Cancer Treatment

5.

Mitoxantrone–Napabucasin Co-Nanoformulation Activates cGAS-STING in HCC Therapy

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

2.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

4.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II

5.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot